The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Checkpoint inhibitors assessment in oropharynx carcinoma (CIAO).
 
Renata Ferrarotto
Research Funding - AstraZeneca/MedImmune (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); OncoMed (Inst)
 
Bonnie S. Glisson
Research Funding - Abbvie/Stemcentrx (Inst); Bristol-Myers Squibb (Inst); ISA Pharmaceuticals (Inst); Medimmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie/Stemcentrx; ISA Pharmaceuticals
 
Diana Bell
No Relationships to Disclose
 
Kate A. Hutcheson
No Relationships to Disclose
 
Jack Phan
No Relationships to Disclose
 
Hai T. Tran
No Relationships to Disclose
 
Dyanne L Gibbs
No Relationships to Disclose
 
J. Jack Lee
No Relationships to Disclose
 
Maura L. Gillison
Consulting or Advisory Role - Aspyerian Therapeutics; AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Andrew G. Sikora
Consulting or Advisory Role - Tessa Therapeutics
Research Funding - Advaxis
Patents, Royalties, Other Intellectual Property - Two provisional patents filed in past year for therapeutic approaches developed in my laboratory.
 
Neil D. Gross
No Relationships to Disclose